• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TAEWOONG MEDICAL CO.,LTD. NITI-S PYLORIC & DUODENAL COVERED STENT; PYLORIC & DUODENAL STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TAEWOONG MEDICAL CO.,LTD. NITI-S PYLORIC & DUODENAL COVERED STENT; PYLORIC & DUODENAL STENT Back to Search Results
Model Number DCT2012BP
Device Problems Migration or Expulsion of Device (1395); Migration (4003)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Type  malfunction  
Manufacturer Narrative
It was reported that after three cycles of chemotherapy, the two duodenal semss had migrated to the transverse colon and it was determined to remove them for avoiding perforation.It is hard to confirm the manufacturing history of the product because the serial number was not informed to us.Migration can be occurred by other company's device as well as ours.It is affected by patient's lesion status, peristalsis of organs, and drug use in general.Based on the description, "the physician commented that the obstruction seemed to be reduced by chemotherapy and it might cause migration," it is assumed that the stent migration occurred due to reduction of obstruction by chemotherapy, not stent malfunction.Through the user manual by taewoong, it is stated that, "potential complications associated with the use of niti-s & comvi stent may include, but are not limited to: migration." the suspected device is not registered in the u.S., and there will be continued to monitor the same, or similar customer complaints.
 
Event Description
An uncovered sems (22mm× 12 cm; next biomedical, korea) and a partially covered sems (dct2012bp) were deployed for the duodenal obstruction.After three cycles of chemotherapy, the two duodenal semss had migrated to the transverse colon, and it was determined to remove them for avoiding perforation.The physician commented that the obstruction seemed to be reduced by chemotherapy and it might cause migration.Influence by placing a covered stent in an uncovered stent is not identified.There were no patient complications as a result of this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NITI-S PYLORIC & DUODENAL COVERED STENT
Type of Device
PYLORIC & DUODENAL STENT
Manufacturer (Section D)
TAEWOONG MEDICAL CO.,LTD.
14, gojeong-ro
wolgot-myeon
gimpo-si, gyeonggi-do 10022
KS  10022
Manufacturer (Section G)
TAEWOONG MEDICAL CO.,LTD.
14, gojeong-ro
wolgot-myeon
gimpo-si, gyeonggi-do 10022
KS   10022
Manufacturer Contact
lee
14, gojeong-ro
wolgot-myeon
gimpo-si, gyeonggi-do 10022
MDR Report Key10703039
MDR Text Key214616004
Report Number3003902943-2020-00086
Device Sequence Number1
Product Code MUM
Combination Product (y/n)Y
Reporter Country CodeJA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 09/24/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberDCT2012BP
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 09/24/2020
Initial Date FDA Received10/20/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-